$WAY

Waystar Holding Corp.

Waystar provides cloud-based software that helps healthcare organizations manage payment workflows and reimbursement. Its clients include physician practices, clinics, surgical centers, laboratories, hospitals and health systems. The platform supports processes across the patient journey, including insurance eligibility and prior authorization, patient billing and payments, claims submission and monitoring, denial appeals, clinical documentation and revenue capture, and analytics and reporting. Waystar AltitudeAI is its proprietary AI engine, used to automate payment-related workflows. Waystar serves over 30,000 clients representing over one million distinct providers. Waystar makes money through subscription fees and volume-based charges under client contracts, which generally include one or both components. Its solutions are sold directly and through channel partners, including electronic health record and practice management providers. Waystar is headquartered in Lehi, Utah.

AlphAI earnings readThird quarter 2026 · NOV 2Waystar Reports Third Quarter 2026 ResultsVerdict: strong

Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.

1
0
0
—
$2.4M
Hawkins Matthew J.
100%
See all $WAY insider activity →
Med

West Virginia University Health System Selects Waystar's AI-Powered Platform to Transform End-to-End Revenue Cycle Operations

West Virginia University Health System (WVU Medicine) selected Waystar's AI-powered platform to consolidate its revenue cycle operations. The deal, the largest in Waystar's history, aims to simplify administrative processes and improve financial performance. Waystar (Nasdaq: WAY) expects the partnership to help WVU Medicine capture full reimbursement and reduce administrative work.

Hawkins Matthew J. sold $2.4M of WAY

Hawkins Matthew J. (Chief Executive Officer) sold 82,500 shares of Waystar Holding Corp. (WAY) at $28.75 ($2.37M total) on 2026-11-10 under a Rule 10b5-1 trading plan.

WAY sentiment & insider activity

Over the past 7 days, AlphAI's AI scored 1 news story mentioning WAY (Waystar Holding Corp.). Coverage has skewed bullish: 1 bullish, 0 neutral, and 0 bearish.

Recent WAY coverage spans financial news, insider activity and earnings.

In the last 30 days, WAY insiders filed 1 SEC Form 4 transaction — no purchases and 1 sale ($2.4M). The most active reporter was Hawkins Matthew J., Chief Executive Officer, with 1 filing. 100% of those filings were made under pre-arranged Rule 10b5-1 plans.

What's driving WAY

  • Contract win should support Waystar’s bookings narrative and reinforce demand for revenue-cycle consolidation software.

    prnewswire.com · Nov 19, 2026

  • The insider sale may signal reduced confidence and could pressure the stock lower.

    SEC EDGAR · Nov 10, 2026

  • Freedom Capital Markets kept its Buy rating on Waystar Holding and increased its price target to $33 from $32, suggesting a 19.3% upside from the Nov 3 close of $27.66. Recent analyst price targets for the company range from $31 to $39.

    tradingview.com · Nov 4, 2026

  • TD Cowen kept its Buy rating on Waystar Holding but reduced its price target to $39 from $42, citing a 7.1% decrease. The new target suggests a 38.6% upside from the Nov 2 close of $28.14. Recent analyst notes on the company have price targets ranging from $31 to $35.

    tradingview.com · Nov 3, 2026

  • Guidance miss and implied Q4 slowdown pressure Waystar lower.

    investing.com · Nov 3, 2026

AlphAI scores every news story that mentions WAY with an AI model for sentiment and relevance, and aggregates insider trades from Waystar Holding Corp.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $WAY

Score
$WAYMedContract· supplier

West Virginia University Health System Selects Waystar's AI-Powered Platform to Transform End-to-End Revenue Cycle Operations

West Virginia University Health System (WVU Medicine) selected Waystar's AI-powered platform to consolidate its revenue cycle operations. The deal, the largest in Waystar's history, aims to simplify administrative processes and improve financial performance. Waystar (Nasdaq: WAY) expects the partnership to help WVU Medicine capture full reimbursement and reduce administrative work.

$WAYHighAI 8/10

Why is Waystar stock sliding today?

Waystar Holding Corp (WAY) stock fell 4.1% in pre-market trading after Q3 earnings. Revenue rose 21% YoY to $325.6M, and adjusted EPS of $0.44 beat estimates. However, full-year 2026 revenue guidance missed expectations, with a midpoint of $1.282B below the $1.29B consensus. Analysts raised price targets but cited concerns over Q4 growth deceleration.

Stocks making the biggest moves midday: Skyworks Solutions, Axon, Dave & Buster's, Revvity & more

Skyworks Solutions (SWKS) and Qorvo (QRVO) rose 10% and 7% respectively, recovering from prior sell-offs. Axon (AXON) fell 9% after a $1B convertible note sale. Revvity (RVTY) jumped 7% to a 52-week high, citing strong backlog. Dave & Buster's (PLAY) dropped 17% after missing Q2 revenue and EBITDA estimates. Enova (ENVA) tumbled 25% after withdrawing a regulatory application. Sysco (SYY) slid 3% on a 12.3M share offering. Alignment Healthcare (ALHC) fell 18% due to business headwinds. Waystar (W

Related tickers